drug · small molecule
ralinepag XR
Phase 3updated 3mo agoby $UTHR UNITED THERAPEUTICS Corp🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
targets
Prostacyclin receptor
all catalysts(0)
nothing on the calendar yet
Trials studying ralinepag XR
- phase3Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects
- phase3A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
- phase3A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- phase1A Study of Ralinepag in Healthy Chinese Adult Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that